A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2007
11/13/2007	US7294703 Vectors with DNA encoding pro polypeptides
11/13/2007	US7294700 Anti-PRO846 antibodies
11/13/2007	US7294698 An isolated Archipelin polypeptide
11/13/2007	US7294694 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes by contacting blood with pro-polypeptides; cancer diagnosis
11/13/2007	US7294692 Vectors with DNA encoding pro polypeptides
11/13/2007	US7294687 For alleviating symptoms of systemic lupus erythematosus (SLE) in a human subject
11/13/2007	US7294615 Compounds that associate on the intermolecular level and aggregate bodies that contain them
11/13/2007	US7294500 Genetic engineering hybrid protein
11/13/2007	US7294477 Allergen and treatment
11/13/2007	US7294473 Methods of identifying substances that interact with JTT-1 protein
11/13/2007	US7294459 Cell regulatory genes, encoded products, and uses related thereto
11/13/2007	US7294339 Method for treating allodynia by peripheral administration of a neurotoxin
11/13/2007	US7294338 Canidae (dog) vaccine comprising an effective amount of a plasmid that contains and expresses in a Canidae host cell a nucleic acid molecule having nucleic acid sequence encoding rabies G
11/13/2007	US7294337 Use of Lactobacillus farciminis for the prevention or treatment of digestive pathologies
11/13/2007	US7294336 Stabilized liquid anti-RSV antibody formulations
11/13/2007	US7294335 PRO19645 antibodies
11/13/2007	CA2220169C Improved methods for the manufacture of magnetically responsive particles
11/13/2007	CA2190515C Vaccine against mycobacterial infections
11/09/2007	CA2547136A1 Novel strain of pseudomonas aeruginosa and related therapeutic components
11/08/2007	WO2007127393A2 Treatment and screening methods for promoting neurogenesis
11/08/2007	WO2007127367A2 Method of prediction of the three-dimensional conformation of flexible proteins
11/08/2007	WO2007127198A2 Protein crosslinkers, crosslinking methods and applications thereof
11/08/2007	WO2007126990A2 Dietary supplements containing probiotics
11/08/2007	WO2007126950A1 Parenteral low dose type 1 interferons for bladder cancer
11/08/2007	WO2007126938A2 Marker for chromosomal abnormalities
11/08/2007	WO2007126887A2 Immunogenic compositions comprising polynucleotides encoding matrix protein 2 and methods of use
11/08/2007	WO2007126876A2 Anti-igf-ir antibodies and uses thereof
11/08/2007	WO2007126825A2 Combined mucosal and parenteral immunization against hiv
11/08/2007	WO2007126816A2 Methods and compositions for vaccination of poultry
11/08/2007	WO2007126788A2 Methods and compositions for the treatment and prevention of viral infection
11/08/2007	WO2007126787A2 Reagents and methods for cancer treatment and prevention
11/08/2007	WO2007126655A1 Eggs having increased antibody titer and methods for making same
11/08/2007	WO2007126455A2 Method for using boc/cdo to modulate hedgehog signaling
11/08/2007	WO2007126439A2 Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r
11/08/2007	WO2007126336A1 Agent exhibiting immunoregulatory properties and the use thereof for treating autoimmune diseases
11/08/2007	WO2007126163A1 B cell-based vaccine loaded with the ligand of natural killer t cell and antigen
11/08/2007	WO2007125940A1 Polypeptide derived from adult cat flea
11/08/2007	WO2007125605A1 Feline cell capable of being cultured without animal protein, and method for production of virus and method for production of vaccine using the feline cell
11/08/2007	WO2007125209A1 Novel polypeptides inducing dendritic cell migration, as well as medicines and pharmaceutical compositions containing same
11/08/2007	WO2007125089A2 Antibodies for the detection of bacillus anthracis and vaccine against b. anthracis infections
11/08/2007	WO2007124698A2 Methods for the treatment of flavivirus infection, molecules and uses thereof
11/08/2007	WO2007124610A1 Antibodies binding to the extracellular domain of the receptor tyrosine kinase alk
11/08/2007	WO2007124573A1 High-titer retroviral packaging cells
11/08/2007	WO2007124529A1 Modulation of t helper cell-mediated immune responses
11/08/2007	WO2007124526A1 Phl p 1 allergen derivative
11/08/2007	WO2007109129A3 Methods for preparing complex multivalent immunogenic conjugates
11/08/2007	WO2007108829A9 Tuberculosis nucleic acids, polypeptides and immunogenic compositions
11/08/2007	WO2007107797A3 Fusion protein comprising an fc receptor binding polypeptide and an antigenic polypeptide for mediating an immune response
11/08/2007	WO2007091030A3 Peptide sequences and compositions
11/08/2007	WO2007087064A9 Pneumococcal serotypes
11/08/2007	WO2007086898A3 Methods and compositions related to anthrax spore glycoproteins
11/08/2007	WO2007081583A3 Anti-pneumococcal preparations and methods of use
11/08/2007	WO2007072221A3 Surface marker-directed cancer therapeutics
11/08/2007	WO2007072214A3 Methods of clustering gene and protein sequences
11/08/2007	WO2007071711A3 Vaccine
11/08/2007	WO2007061969A3 Vaccines against influenza a and influenza b
11/08/2007	WO2007059528A3 Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
11/08/2007	WO2007057778A3 Recombinant polypeptides and methods for detecting and/or quantifying autoantibodies against tsh receptor
11/08/2007	WO2007035897A3 Improved live attenuated vaccine strain for prevention of tularemia
11/08/2007	WO2007025388A3 Anti-apoptotic protein antibodies
11/08/2007	WO2006110883A8 Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
11/08/2007	WO2006085983A3 Viral adjuvants
11/08/2007	WO2006047517A3 Live attenuated bacterial vaccine to reduce or inhibit carriage and shedding of enterohemorrhagic escherichia coli in cattle
11/08/2007	US20070259969 Using CD44 expression profile as diagnostic indicator of cell proliferative disorders
11/08/2007	US20070259831 Treatment and screening methods for promoting neurogenesis
11/08/2007	US20070259815 Albumin fusion proteins
11/08/2007	US20070259422 isolated nucleic acid encoding an immunogenic peptide recognized by T lymphocytes; host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/08/2007	US20070259400 Antibodies
11/08/2007	US20070259383 Novel Genes involved in Epidermal differentiation, and uses thereof
11/08/2007	US20070259006 Shed antigen vaccine with dendritic cells adjuvant
11/08/2007	US20070259005 Method of treating cancer
11/08/2007	US20070259004 Expression vector for Bacillus species
11/08/2007	US20070259003 Clostridial toxin derivatives and methods for treating pain
11/08/2007	US20070259002 Botulinum Toxin Therapy of Heart Rhythm Disorders
11/08/2007	US20070259001 Cosmetic use of botulinum toxin for the treatment of eyebrow and forehead ptosis, and unwanted eyebrow expression
11/08/2007	US20070259000 administering botulinum toxin to testicle and/or connective tissue associated therewith; post vasectomy pain
11/08/2007	US20070258999 Sars Virus Nucleotide and Amino Acid Sequences and Uses Thereof
11/08/2007	US20070258997 Rescue of mumps virus from CDNA
11/08/2007	US20070258994 Immunomodulatory formulations and methods for use thereof
11/08/2007	US20070258993 Dna-Carrier Conjugate
11/08/2007	US20070258992 Clostridial peptide for preventing or reducing immunoresistance to botulinum toxin therapy in humans and/or other mammals
11/08/2007	US20070258991 Immunogenic agent therapy using plasmapheresis
11/08/2007	US20070258990 Means and Methods for Detecting and/or Staging Follicular Lymphoma Cells
11/08/2007	US20070258989 Immunomodulatory pharmaceutical composition and a process for preparation thereof
11/08/2007	US20070258988 Identification and Characterization of Multiple Splice Variants of the Mu Opioid Receptor Gene
11/08/2007	US20070258987 Recombinant Anti-Cd30 Antibodies and Uses Thereof
11/08/2007	US20070258986 Targeted Delivery System for Bioactive Agents
11/08/2007	US20070258985 Human mini-antibody cytotoxic for tumor cells which express the ERB-B2 receptor
11/08/2007	US20070258984 Anti-neoplastic composition of 5-FU, leucovorin, irinotecan, oxaliplatin, capecitabine, paclitaxel or doxetaxel; breast cancer, colorectal cancer, rectal cancer, non-small cell lung cancer, non-Hodgkins lymphoma (NHL), renal cell cancer, prostate cancer, liver cancer
11/08/2007	US20070258983 Selective adsorption of a broader spectrum of stimulators or mediators, including cytokines to restore immunologic stability; counters the immunologic instability of sepsis; autoregulation: as one component of the response increased so too is the effect on that component
11/08/2007	US20070258982 Methods of using antibodies against human IL-22
11/08/2007	US20070258981 Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
11/08/2007	US20070258980 Vascular endothelial cell growth factor antagonists and uses thereof
11/08/2007	US20070258979 Interlukin receptor specific immunoglobulin for use in treatment and prevention of severe asthma, atopic dermatitis, fibrotic and chronic obstructive pulmonary diseases
11/08/2007	US20070258978 Immunogenic Recombinant Antibody
11/08/2007	US20070258977 Inhibiting OX-2 (also called CD200) gene expression to treat a tumor that is associated with increased CD200 expression; leukemia; phage display screening for antigens; monoclonal antibodies; fusion proteins; use of OX-2 preventing graft rejection, autoimmune disease, and in inducing tumor cell growth
11/08/2007	US20070258976 Combination Therapy for Diseases Involving Angiogenesis
11/08/2007	US20070258975 Crystallization of Antibody or Fragment Thereof
11/08/2007	US20070258974 Diagnostics and Therapeutics for Diseases Associated with Puromycin Sensitive Aminopeptidase Npepps (Npepps)
11/08/2007	US20070258973 Diagnostics and Therapeutics for Diseases Associated with Tripeptidyl-Peptidase 2(Tpp2)

1 ... 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 ... 1823